TOP HEADLINES

Featured Story

  • GSK, Medidata report on positive pilot of mHealth in clinical trials

    GlaxoSmithKline and Medidata have moved mHealth tools one step closer to the clinical trial mainstream. Having run a pilot project, the partners have concluded that mHealth technologies can deliver reliable, FDA-compliant data and improve the clinical trial experience for patients.

NCI sees role for feds in validating, processing wearables data

A program director at the National Cancer Institute has outlined his vision for how federal IT initiatives can help healthcare adapt to the rise of wearables and ever larger datasets. The process will begin by identifying the core analytic and IT system components all researchers need, regardless of whether they are focused on cancer, diabetes or other diseases.

Cambrian raises $10M for DNA printing tech used by GSK

Proponents of DNA printing have heralded it as a way to do everything from bringing alien life back from Mars to delivering vaccines in the event of a pandemic. And the technology has attracted GlaxoSmithKline and Roche, both of which have taken an interest in Cambrian Genomics.

NIH cites European precedent in call for disclosure of clinical trial data

If the U.S. National Institutes of Health gets its way, any researcher it funds will have to publish a summary of their clinical trial results and adverse events, regardless of whether the trial succeeded or failed.

Johns Hopkins, Scripps create modeling tools for Ebola R&D

Top academic centers have contributed structural modeling tools to the push to develop treatments for Ebola. A team at Scripps is behind the first tool, which is designed to show researchers which parts of the Ebola virus to target.

Venter's HLI inks deal to access registry of 11,000 twins

J. Craig Venter's Human Longevity, Inc. has added another piece to the data tapestry it is creating. The new addition is a registry of 11,000 twins, complete with phenotypic information and paired samples.

MORE NEWS